Nussbaumer-Streit, Barbara
Pjrek, Edda
Kien, Christina
Gartlehner, Gerald
Bartova, Lucie
Friedrich, Michaela-Elena
Kasper, Siegfried
Winkler, Dietmar
Article History
Received: 1 December 2017
Accepted: 9 November 2018
First Online: 26 November 2018
Ethics approval and consent to participate
: The study was approved by and registered with the ethical review board of the Medical University of Vienna (EC No. 1586/2015). All interviewees read and signed the informed consent sheet before the interviews were conducted.
: Not applicable.
: Without any relevance to this work, Dr. Kasper received grants/research support, consulting fees and/or honoraria within the last three years from Angelini, AOP Orphan Pharmaceuticals AG, Celegne GmbH, Eli Lilly, Janssen-Cilag Pharma GmbH, KRKA-Pharma, Lundbeck A/S, Mundipharma, Neuraxpharm, Pfizer, Sanofi, Schwabe, Servier, Shire, Sumitomo Dainippon Pharma Co. Ltd., and Takeda.. Dr. Pjrek has received travel grants from AOP Orphan. Dr. Winkler received travel grants and/or speaker honoraria from Angelini, AOP Orphan, Bristol-Myers Squibb, Lundbeck, Pfizer, and Servier.Barbara Nussbaumer-Streit, Christina Kien, Dr. Gerald Gartlehner, Dr. Michaela-Elena Friedrich, and Dr. Lucie Bartova have no conflict of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.